# Syndecan 1 as Biomarker for Inflammation

> **NCT02333526** · — · UNKNOWN · sponsor: **Helios Albert-Schweitzer-Klinik Northeim** · enrollment: 44 (estimated)

## Conditions studied

- Colitis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02333526
- **Lead sponsor:** Helios Albert-Schweitzer-Klinik Northeim
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12
- **Primary completion:** 2019-12
- **Final completion:** 2020-07
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2019-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02333526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02333526, "Syndecan 1 as Biomarker for Inflammation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02333526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*